Efficacy of HAD Induction With Intensified Cytarabine in Newly-diagnosed CEBPA Double Mutated Acute Myeloid Leukemia

NCT04415008 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

61

Enrollment

OTHER

Sponsor class

Conditions

CEBPA Double Mutation
Acute Myeloid Leukemia

Interventions

DRUG: HAD induction with intermediate dose cytarabine

Sponsor

Institute of Hematology & Blood Diseases Hospital, China